| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/29/1993 | CA2121816A1 Substituted heterocycles as angiotensin ii antagonists |
| 04/29/1993 | CA2121815A1 Substituted aminopyrimidines as angiotensine ii antagonists |
| 04/29/1993 | CA2121814A1 Pyrimidocycloalkanes as angiotensin ii antagonists |
| 04/29/1993 | CA2121801A1 N-(mercaptoacyl)amino acids, methods of their preparation and therapeutic use, and pharmaceutical compositions containing them |
| 04/29/1993 | CA2121127A1 Lymphokine gene therapy of cancer |
| 04/29/1993 | CA2120927A1 Enhanced skin penetration system for improved topical delivery of drugs |
| 04/29/1993 | CA2120917A1 External preparation for treating hemorrhoidal diseases |
| 04/29/1993 | CA2120915A1 Tricyclic quinoxalinediones |
| 04/29/1993 | CA2120911A1 Medicaments |
| 04/29/1993 | CA2120234A1 2-aminopropan-1,3-diol chemotherapeutic agents |
| 04/29/1993 | CA2119875A1 Benzodiazepine derivatives, compositions containing them and their use in therapy |
| 04/29/1993 | CA2118920A1 Benzo-isoquinoline derivatives and analogs and their use in therapeutics |
| 04/29/1993 | CA2118802A1 Imidazole derivatives and pharmaceutical compositions containing the same |
| 04/29/1993 | CA2116337A1 Oxazolidone derivative |
| 04/29/1993 | CA2116036A1 Device for the transdermal administration of melatonin |
| 04/29/1993 | CA2115848A1 Substituted heterocyclic derivatives useful as platelet aggregation inhibitors |
| 04/29/1993 | CA2099270A1 Quinoxaline derivatives with affinity for quisqualate-receptors |
| 04/29/1993 | CA2081537A1 Quinoline derivatives, process for their preparation, and their therapeutic applications |
| 04/29/1993 | CA2081300A1 2-aminomethyl-chromans |
| 04/29/1993 | CA2081256A1 Triazaspirodecanone-methylchromans |
| 04/28/1993 | EP0539343A1 Substituted heterocyclic derivatives useful as platelet aggregation inhibitors |
| 04/28/1993 | EP0539336A1 Use of L-carnitine or of acyl L-carnitine for the treatment of idiopathic oligoasthenospermias |
| 04/28/1993 | EP0539330A1 Process for the preparation of substituted indoles |
| 04/28/1993 | EP0539329A1 Acetenyl compounds useful as leukotrien antagonists |
| 04/28/1993 | EP0539326A2 Bis (phenyl)ethane derivatives |
| 04/28/1993 | EP0539319A2 Pharmaceutical cyclosporin composition |
| 04/28/1993 | EP0539281A1 New naphthamides, process for their preparation and their application in the therapeutical field |
| 04/28/1993 | EP0539215A1 Penetration enhancement of topically applied formulations |
| 04/28/1993 | EP0539204A1 Antiviral 4-substituted-2-deoxy-2,3-didehydro derivatives of alpha D-neuraminic acid |
| 04/28/1993 | EP0539192A1 HIV Protease inhibitors |
| 04/28/1993 | EP0539180A1 Antiviral agents |
| 04/28/1993 | EP0539170A1 Benzodiazepine derivatives and their use as antagonists of cholecystokinin and/or gastrin receptors |
| 04/28/1993 | EP0539164A1 Nitrogen-containing tetracyclic compounds having anti-allergic and anti-asthmatic activities, their preparation and use |
| 04/28/1993 | EP0539154A1 Acridine-1,8-dione-derivatives as therapeutic agents |
| 04/28/1993 | EP0539153A1 Acridine derivative as therapeutic agent |
| 04/28/1993 | EP0539117A1 Compounds useful as leukotriene antagonists |
| 04/28/1993 | EP0539086A2 Condensed pyrimidine derivatives and their use as angiotensine II antagonists |
| 04/28/1993 | EP0539066A1 Heterocyclic compounds useful as angiotensin II antagonists |
| 04/28/1993 | EP0539057A1 Benzimidazole phosphono-amino acids |
| 04/28/1993 | EP0538911A2 Chemical prevention or reversal of cataract by phase separation inhibitors |
| 04/28/1993 | EP0538898A2 Cytotoxic bicyclo (7.3.1)-tridec-4-ene-2,6-diyne compounds and process for the preparation thereof |
| 04/28/1993 | EP0538897A1 The use of BMY 14802 in the treatment of anxiety in benzodiazepine-withdrawn patients |
| 04/28/1993 | EP0538858A1 Improved lyophilized ifosfamide compositions |
| 04/28/1993 | EP0538844A2 Tetrahydroprotoberberine quaternary ammonium compounds and the process for preparing thereof |
| 04/28/1993 | EP0538783A1 N-phenyl-2-cyano-3-hydroxycrotonic acid amid derivatives and their use as medicaments having immunomodulating properties |
| 04/28/1993 | EP0538692A1 Use of partly known substituted pyrrolidine derivatives as pharmaceuticals, new compounds and process for their preparation |
| 04/28/1993 | EP0538691A1 Substituted tetrahydrothiophenes, methods for their preparation, and their use in pharmaceutical compositions |
| 04/28/1993 | EP0538690A1 Arylquinoline substituted 1,4-dihydropyridine dicarboxylic derivatives, process for their preparation and their use as drugs |
| 04/28/1993 | EP0538689A1 Substituted 2,3-dihydropyrans, method for their preparation and their use as medicaments |
| 04/28/1993 | EP0538688A1 Substituted tetrahydrofurans, methods for their preparation, and their use as pharmaceutical compositions |
| 04/28/1993 | EP0538517A1 Novel organo-tin compounds having anti-tumour activity and anti-tumour compositions |
| 04/28/1993 | EP0538505A1 Process for the preparation of 4-hydroxy-2-oxo-pyrrolidinyl-1-acetamide |
| 04/28/1993 | EP0538486A1 Sewing machine needle and method of manufacturing same |
| 04/28/1993 | EP0538477A1 Novel cyclic aminophenylacetic acid derivative, production thereof, and immune response modulator containing the same as active ingredient |
| 04/28/1993 | EP0538476A1 Preventive or remedy for ischemia, reperfusion-induced tissue disorder and arrhythmia as well as pulmonary disorder caused by activated oxygen free radical |
| 04/28/1993 | EP0538469A1 Sulfonanilide derivative and medicine |
| 04/28/1993 | EP0538436A1 Novel quaternary ammonium salts, process for obtaining same and pharmaceutical compositions containing them |
| 04/28/1993 | EP0538433A1 Agent suitable for transdermal administration containing ergolin derivatives |
| 04/28/1993 | EP0538422A1 New use of diphenylbutylpiperazinecarboxamides in the treatment of substance disorders |
| 04/28/1993 | EP0538396A1 Inhibitors of retroviral proteases |
| 04/28/1993 | EP0538392A1 3-phenyl-5,6-dihydrobenz c]acridine-7-carboxylic acids and related compounds as immunosuppresive agents |
| 04/28/1993 | EP0538384A1 Oxamides |
| 04/28/1993 | EP0538383A1 Inhibitors of aspartic proteases |
| 04/28/1993 | EP0538373A1 Anti-herpes virus and cytomegalovirus oligomers |
| 04/28/1993 | EP0538348A1 Process for producing unsaturated 17-alpha-cyanomethyl-17-beta-hydroxysteroids. |
| 04/28/1993 | EP0538340A1 Therapeutic use of piperidine-2,6-diones |
| 04/28/1993 | EP0538337A1 Drug for reducing intraocular pressure. |
| 04/28/1993 | EP0538330A1 Beta-alethine use in cell culture and therapy. |
| 04/28/1993 | EP0538313A1 Topical ophthalmic suspensions |
| 04/28/1993 | EP0538312A1 Anti-androgenic [3,2-d]triazole steroids |
| 04/28/1993 | EP0538297A1 Antiviral tetrahydroimidazo 1,4]benzodiazepin-2-(thio)ones |
| 04/28/1993 | EP0538262A1 N-dimethoxy phenyl alkyl-n'-imidazolyl phenyl amidine derivatives and process thereof |
| 04/28/1993 | EP0538248A1 Tetrahydroisoquinolinylcarbamates of 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo [2,3-b]indole |
| 04/28/1993 | EP0485530A4 Tgf--g(b) protein compositions for inhibition of cell proliferation |
| 04/28/1993 | EP0483213A4 Transdermal administration of lisuride |
| 04/28/1993 | EP0302097B1 Pharmaceutical compositions for treating obstructive air passage diseases |
| 04/28/1993 | EP0283513B1 Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic, vascular, cardiovascular, and/or thrombotic diseases |
| 04/28/1993 | CN1071433A Digestive tract contractile motion stimulant |
| 04/28/1993 | CN1071432A Crystalline etoposide 4'-phosphate diethanelate |
| 04/28/1993 | CN1071430A Macrolide compounds, their preparation and their use |
| 04/28/1993 | CN1071428A Pyrroliaylthiocarbapenem derivatives |
| 04/28/1993 | CN1071427A 6-benzoxazinyl and 6-benzothiazinyl-2,3,4,5-tetraiiydropyridazin-3-ones |
| 04/28/1993 | CN1071426A Process for the preparation of novel acylals of imidazole-5-carboxylic acid derivatives |
| 04/28/1993 | CN1071423A Bicyclic carboxylic acid derivatives |
| 04/28/1993 | CN1071420A 4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl) phenyl)-5-methyl-3h-1,2,4-triazol-3-one derivatives |
| 04/28/1993 | CN1071418A Benzo (f) quinolinones |
| 04/28/1993 | CN1071416A N-alkyl-3-phenyl-3-(2-alkylthiophe-noxy) propylamines |
| 04/28/1993 | CN1071415A Novel 9-amino-7-substituted-6-demethyl-6-deoxytetracyclines |
| 04/28/1993 | CN1071334A Solid for mulation containing amide derivative and process for preparing same |
| 04/28/1993 | CN1071333A Calcium receptor active molecules |
| 04/27/1993 | US5206428 Anticoagulants |
| 04/27/1993 | US5206420 Process for the preparation of succinylcholine halides |
| 04/27/1993 | US5206415 Modulation of gamma-aminobutyric acid receptor channel function |
| 04/27/1993 | US5206403 Antiagglomerants |
| 04/27/1993 | US5206384 Actinonin derivatives and pharmaceutically acceptable salts thereof |
| 04/27/1993 | US5206382 Indole derivatives, pharmaceutical compositions and methods of treating neurological and psychiatric disorders |
| 04/27/1993 | US5206377 Melatonin antagonist |
| 04/27/1993 | US5206373 Process for preparing fibrinogen receptor antagonists |
| 04/27/1993 | US5206366 Process for preparing aryl piperazinyl-heterocyclic compounds |
| 04/27/1993 | US5206356 Therapy and diagnosis of metastatic metabolic states |